Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Reduction of the dose of radiotherapy to the elective neck in head and neck squamous cell carcinoma; a randomized clinical trial. Effect on late toxicity and tumor control.

Nevens D, Duprez F, Daisne JF, Dok R, Belmans A, Voordeckers M, Van den Weyngaert D, De Neve W, Nuyts S.

Radiother Oncol. 2017 Feb;122(2):171-177. doi: 10.1016/j.radonc.2016.08.009. Epub 2016 Aug 12.

PMID:
27528118
2.

HPV-related oropharyngeal cancers in Flanders (Belgium): a multicenter study.

Van Limbergen EJ, Dok R, Laenen A, Hauben E, Van den Weyngaert D, Voordeckers M, De Neve W, Duprez F, Nuyts S.

B-ENT. 2014;10(1):7-14.

PMID:
24765823
3.

Reduction of the dose to the elective neck in head and neck squamous cell carcinoma, a randomized clinical trial using intensity modulated radiotherapy (IMRT). Dosimetrical analysis and effect on acute toxicity.

Nuyts S, Lambrecht M, Duprez F, Daisne JF, Van Gestel D, Van den Weyngaert D, Platteaux N, Geussens Y, Voordeckers M, Madani I, De Neve W.

Radiother Oncol. 2013 Nov;109(2):323-9. doi: 10.1016/j.radonc.2013.06.044. Epub 2013 Aug 13.

PMID:
23953410
4.

Health-related quality of life in survivors of stage I-II breast cancer: randomized trial of post-operative conventional radiotherapy and hypofractionated tomotherapy.

Versmessen H, Vinh-Hung V, Van Parijs H, Miedema G, Voordeckers M, Adriaenssens N, Storme G, De Ridder M.

BMC Cancer. 2012 Oct 25;12:495. doi: 10.1186/1471-2407-12-495.

5.

Early contralateral shoulder-arm morbidity in breast cancer patients enrolled in a randomized trial of post-surgery radiation therapy.

Adriaenssens N, Vinh-Hung V, Miedema G, Versmessen H, Lamote J, Vanhoeij M, Lievens P, van Parijs H, Storme G, Voordeckers M, De Ridder M.

Breast Cancer (Auckl). 2012;6:79-93. doi: 10.4137/BCBCR.S9362. Epub 2012 Jul 30.

6.

Parotid gland sparing with helical tomotherapy in head-and-neck cancer.

Voordeckers M, Farrag A, Everaert H, Tournel K, Storme G, Verellen D, De Ridder M.

Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):443-8. doi: 10.1016/j.ijrobp.2011.11.070. Epub 2012 Jul 25.

PMID:
22836056
7.

Diagnostic and prognostic correlates of preoperative FDG PET for breast cancer.

Vinh-Hung V, Everaert H, Lamote J, Voordeckers M, van Parijs H, Vanhoeij M, Verfaillie G, Fontaine C, Vees H, Ratib O, Vlastos G, De Ridder M.

Eur J Nucl Med Mol Imaging. 2012 Oct;39(10):1618-27. Epub 2012 Jul 10.

PMID:
22777335
8.

Scapula alata in early breast cancer patients enrolled in a randomized clinical trial of post-surgery short-course image-guided radiotherapy.

Adriaenssens N, De Ridder M, Lievens P, Van Parijs H, Vanhoeij M, Miedema G, Voordeckers M, Versmessen H, Storme G, Lamote J, Pauwels S, Vinh-Hung V.

World J Surg Oncol. 2012 May 16;10:86. doi: 10.1186/1477-7819-10-86.

9.

Can 18-FDG-PET during radiotherapy replace post-therapy scanning for detection/demonstration of tumor response in head-and-neck cancer?

Ceulemans G, Voordeckers M, Farrag A, Verdries D, Storme G, Everaert H.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):938-42. doi: 10.1016/j.ijrobp.2010.07.019. Epub 2010 Oct 6.

PMID:
20932677
10.

Pattern of failure after helical tomotherapy in head and neck cancer.

Farrag A, Voordeckers M, Tournel K, De Coninck P, Storme G.

Strahlenther Onkol. 2010 Sep;186(9):511-6. doi: 10.1007/s00066-010-2130-5. Epub 2010 Aug 30.

PMID:
20803182
11.

Can 18F-FDG-PET response during radiotherapy be used as a predictive factor for the outcome of head and neck cancer patients?

Farrag A, Ceulemans G, Voordeckers M, Everaert H, Storme G.

Nucl Med Commun. 2010 Jun;31(6):495-501. doi: 10.1097/MNM.0b013e3283334e2b.

PMID:
20351599
12.

Survival benefit with radiation therapy in node-positive breast carcinoma patients.

Voordeckers M, Vinh-Hung V, Lamote J, Bretz A, Storme G.

Strahlenther Onkol. 2009 Oct;185(10):656-62. doi: 10.1007/s00066-009-2047-z. Epub 2009 Oct 6.

PMID:
19806330
13.

Longitudinal assessment of parotid function in patients receiving tomotherapy for head-and-neck cancer.

Voordeckers M, Everaert H, Tournel K, Verellen D, Baron I, Van Esch G, Vanhove C, Storme G.

Strahlenther Onkol. 2008 Aug;184(8):400-5.

PMID:
18956516
14.

An assessment of the use of skin flashes in helical tomotherapy using phantom and in-vivo dosimetry.

Tournel K, Verellen D, Duchateau M, Fierens Y, Linthout N, Reynders T, Voordeckers M, Storme G.

Radiother Oncol. 2007 Jul;84(1):34-9. Epub 2007 Jun 27.

PMID:
17590468
15.

From linac to tomotherapy: new possibilities for cure?

Storme G, Verellen D, Soete G, Linthout N, Van De Steene J, Voordeckers M, Vinh-Hung V, Tournel K, Van Den Berge D.

Adv Exp Med Biol. 2006;587:303-8. Review. No abstract available.

PMID:
17163173
16.

Modeling the effect of age in T1-2 breast cancer using the SEER database.

Tai P, Cserni G, Van De Steene J, Vlastos G, Voordeckers M, Royce M, Lee SJ, Vinh-Hung V, Storme G.

BMC Cancer. 2005 Oct 8;5:130.

17.

Statistical interaction in the survival analysis of early breast cancer using registry data: role of breast conserving surgery and radiotherapy.

Vinh-Hung V, Burzykowski T, Van de Steene J, Voordeckers M, Lamote J, Storme G.

Tumori. 2005 Jan-Feb;91(1):9-14.

PMID:
15849998
18.

Ratios of involved nodes in early breast cancer.

Vinh-Hung V, Verschraegen C, Promish DI, Cserni G, Van de Steene J, Tai P, Vlastos G, Voordeckers M, Storme G, Royce M.

Breast Cancer Res. 2004;6(6):R680-8. Epub 2004 Oct 6.

19.

The lymph node ratio as prognostic factor in node-positive breast cancer.

Voordeckers M, Vinh-Hung V, Van de Steene J, Lamote J, Storme G.

Radiother Oncol. 2004 Mar;70(3):225-30.

PMID:
15064006
20.

Adjuvant radiotherapy after mastectomy for pT1-pT2 node negative (pN0) breast cancer: is it worth the effort?

Voordeckers M, Van de Steene J, Vinh-Hung V, Storme G.

Radiother Oncol. 2003 Sep;68(3):227-31.

PMID:
13129629

Supplemental Content

Loading ...
Support Center